$3.00
−1.07 (−26.29%)Oct 27, 2026, 8:00 PM ET
Market Closed
Video Interviews
View All Interviews →
Company Overview
Davion Healthcare Plc is an Irish public limited company that develops and commercializes non-invasive home tests for the early detection of health anomalies, including cancers. Its products use thermography: a liquid crystal film placed on the skin shows temperature differences as color shifts, and AI analysis of smartphone images interprets the result. It has four completed tests, BreastCheck, FootFlow (diabetic circulation), Testic and ThermaDerm, all non-diagnostic Class I devices. BreastCheck and FootFlow have been FDA-registered, and registered in the EU and UK, since November 2023. The company was incorporated in Cyprus in 2022 and re-domiciled to Ireland in 2024, keeping a wholly owned Cyprus subsidiary.
Key Highlights
- Medical - Devices · Healthcare
- Led by Glenn Williams
Analyst Coverage
View All Coverage →No analyst coverage available.
Economic Calendar
View more →- Oct 28
FOMC Meeting
2:00 PM ET
- Oct 28
FOMC Rate Decision
2:00 PM ET
- Oct 28
FOMC Press Conference
2:30 PM ET
- Oct 29
Initial Jobless Claims
8:30 AM ET
Crypto Prices
View more →
Bitcoin (BTC)
81,018 +1.56%
Stock Quote
View Full Quote →NASDAQ:DAVI
Davion Healthcare Plc
$3.00
−1.07 (−26.29%)- Day Range
- $2.78 – $3.99
- 52 Week Range
- 2.7801-12.3
- Volume
- 3,473,484
- Avg. Volume
- 472,905
- Market Cap
- 75M
- Shares Outstanding
- —
Market data delayed by 15 minutes.
Company Facts
- Sector
- Healthcare
- Industry
- Medical - Devices
- Headquarters
- Cork, IE
- Incorporated
- Oct 22, 2026
- Website
